ANIP - ANI Pharmaceuticals Inc. (ANIP) CEO Nikhil Lalwani on Q1 2022 Results - Earnings Call Transcript
ANI Pharmaceuticals, Inc. (ANIP) Q1 2022 Earnings Conference Call May 10, 2022 8:30 a.m. ET Company Participants Lisa Wilson - Investor Relations Nikhil Lalwani - President and Chief Executive Officer Steve Carey - Chief Financial Officer Chris Mutz - Head of Rare Disease Conference Call Participants Elliot Wilbur - Raymond James Brandon Folkes - Cantor Fitzgerald Presentation Operator Good day, everyone, and welcome to First Quarter 2022 Call. At this time, all participants are in a listen-only mode. Later, you will have an opportunity to ask questions during question-and-answer session. [Operator Instructions] Please note this call may be recorded. It is now my pleasure to turn today's program over to Lisa Wilson, Investor Relations for ANI. Lisa Wilson Thank you, Emma. Welcome to ANI Pharmaceuticals' Q1 2022 earnings results call. This is Lisa Wilson, Investor Relations for ANI. With me on today's call are Nikhil Lalwani, President and Chief Executive
For further details see:
ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q1 2022 Results - Earnings Call Transcript